Applied DNA Sciences Inc (OTCMKTS:APDN) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued on Friday, June 2nd.

Separately, Maxim Group set a $6.00 price objective on Applied DNA Sciences and gave the stock a “buy” rating in a research report on Thursday, April 6th.

Shares of Applied DNA Sciences (APDN) traded down 8.33% during trading on Friday, hitting $1.10. The stock had a trading volume of 42,904 shares. The firm’s market cap is $28.99 million. The firm’s 50-day moving average is $1.44 and its 200 day moving average is $1.75. Applied DNA Sciences has a 52-week low of $1.05 and a 52-week high of $3.61.

Applied DNA Sciences (OTCMKTS:APDN) last posted its quarterly earnings results on Thursday, May 11th. The technology company reported ($0.13) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.14) by $0.01. Applied DNA Sciences had a negative net margin of 378.72% and a negative return on equity of 128.10%. The company had revenue of $0.91 million during the quarter, compared to the consensus estimate of $1.25 million. During the same period last year, the firm earned ($0.14) EPS. The company’s revenue for the quarter was up 59.6% on a year-over-year basis. On average, analysts expect that Applied DNA Sciences will post ($0.35) EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Applied DNA Sciences Inc (APDN) Downgraded by ValuEngine to “Strong Sell”” was originally published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/06/13/applied-dna-sciences-inc-apdn-downgraded-by-valuengine-to-strong-sell.html.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Applied DNA Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.